2021 American Transplant Congress
Sars-cov-2 Stat Testing for Organ Donation; One Laboratory’s Experience
*Purpose: The COVID-19 pandemic took the U.S. by storm. The Transplant Community had to navigate through unprecedented scenarios in order to continue the life-saving mission…2021 American Transplant Congress
Impact of a “COVID-free” Pathway on Living Donor Transplantation During a Pandemic
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: COVID-19 pandemic has significantly decreased rates of organ transplantation, with most programs curtailing living donor transplantations. This has led to an increase in waitlist…2021 American Transplant Congress
Has the Proportional Rise in Deceased Organ Donation Rate Over Last 5 Years Been Optimal? Data-based, Forecasting Model Analysis of UNOS/NHSBT UK Donor Data
*Purpose: The increase in deceased donor numbers since last decade has been widely reported. We aim to analyse if the trend in rise of numbers…2021 American Transplant Congress
SARS-CoV-2 Infection in Solid Organ Transplant Recipients: A Retrospective Cohort Study
Infectious Diseases, University of Massachusetts, Worcester, MA
*Purpose: Initial studies of COVID-19 in solid organ transplant (SOT) recipients demonstrated high mortality rates, but more recent comparative data shows contradictory results.*Methods: We evaluated…2021 American Transplant Congress
Mitigating the Adverse Impact of Broader Kidney Sharing with Hospital-based Machine Perfusion
Hackensack University Medical Center, Hackensack, NJ
*Purpose: The new UNOS kidney allocation changes effective December 2020 will be removing the geographic limits of donation service areas (DSA) and UNOS regions favoring…2021 American Transplant Congress
Creating a Culturally Sensitive Report Card for African American Kidney Transplant Candidates: Preliminary Results from Pilot Interviews and Focus Groups
*Purpose: Racial disparities in kidney transplantation continue to negatively impact African American (AA) patients despite changes to deceased donor allocation practices. AA patients are overrepresented…2021 American Transplant Congress
Characterization of SGLT2 Inhibitor Use After Abdominal Transplant
*Purpose: Post solid organ transplantation, diabetic kidney disease (DKD) can progress due to recurrent pre-transplantation diabetes or the development of post-transplantation diabetes mellitus (PTDM). This…2021 American Transplant Congress
Realistic Targets for Transplantation Among Incident Kidney Failure Patients in the United States
University of British Columbia, Vancouver, BC, Canada
*Purpose: The Executive Order on Advancing American Kidney Health aims to treat 80% of all kidney failure patients with transplantation or home dialysis but no…2021 American Transplant Congress
Hospitalization in the First Year After Kidney Transplantation: Analyses to Identify Common Predictors of Risk Across Recipient Sensitization Groups
University of Florida, Gainesville, FL
*Purpose: We investigated the risk of hospitalization associated with baseline risk factors in adult deceased donor (DD) kidney transplant (KT) recipients (KTRs) stratified into calculated…2021 American Transplant Congress
Bamlanivimab for Covid-19 in Kidney Transplant Patients
Nephrology, Indiana University School of Medicine, Indianapolis, IN
*Purpose: Treatment options for patients with COVID 19 have limited efficacy in reducing severity and duration of viral symptoms as well as progression to severe…
- « Previous Page
- 1
- …
- 269
- 270
- 271
- 272
- 273
- …
- 1683
- Next Page »